Rchr
J-GLOBAL ID:202201004470825100
Update date: Aug. 21, 2024
Kajikuri Junko
Kajikuri Junko
Research theme for competitive and other funds (3):
- 2014 - 2017 Elucidating the mechanism of vascular dysfunction to achieve gender-specific medicine
- 2013 - 2017 Roles of endothelium-derived hyperpolarizing factor to reduce intimal hyperplasia
- 2011 - 2013 Mechanism of vascular dysfunction with continuous hyperglicemia or postprandial hyperglycemia and development of treatment strategy
Papers (84):
-
Susumu Ohya, Hiroaki Kito, Junko Kajikuri, Yohei Yamaguchi, Miki Matsui. Transcriptional Up-Regulation of FBXW7 by KCa1.1 K+ Channel Inhibition through the Nrf2 Signaling Pathway in Human Prostate Cancer LNCaP Cell Spheroid Model. International Journal of Molecular Sciences. 2024. 25. 11. 6019-6019
-
Hiroaki Kito, Reiko Kawagishi, Takusei Ryu, Kyoko Endo, Junko Kajikuri, Wayne R. Giles, Susumu Ohya. KCa3.1 regulates cell cycle progression by modulating Ca2+ signaling in murine preosteoblasts. Journal of Pharmacological Sciences. 2023. 153. 3. 142-152
-
Susumu Ohya, Miki Matsui, Junko Kajikuri, Hiroaki Kito, Kyoko Endo. Downregulation of IL-8 and IL-10 by the Activation of Ca2+-Activated K+ Channel KCa3.1 in THP-1-Derived M2 Macrophages. International journal of molecular sciences. 2022. 23. 15
-
Matsui Miki, Kajikuri Junko, Endo Kyoko, Kito Hiroaki, Ohya Susumu. KCa3.1 inhibition-induced activation of the JNK/c-Jun signaling pathway enhances IL-10 expression in peripherally-induced regulatory T cells. Journal of Pharmacological Sciences (Web). 2022. 148. 1. 1-5
-
Susumu Ohya, Junko Kajikuri, Kyoko Endo, Hiroaki Kito, Miki Matsui. KCa1.1 K+ Channel Inhibition Overcomes Resistance to Antiandrogens and Doxorubicin in a Human Prostate Cancer LNCaP Spheroid Model. International journal of molecular sciences. 2021. 22. 24
more...
MISC (47):
-
松井未来, 梶栗潤子, 遠藤京子, 鬼頭宏彰, 大矢進. Increase in IL-10 expression by KCa3.1 inhibition in peripherally-induced regulatory T cells. 日本薬学会年会要旨集(Web). 2022. 142nd
-
大矢進, 梶栗潤子, 鬼頭宏彰, 遠藤京子, 松井未来. Overcome of resistance to antiandrogens by Ca2+-activated K+ channel inhibition in a prostate cancer spheroid model. 日本薬学会年会要旨集(Web). 2022. 142nd
-
大矢進, 松井未来, 梶栗潤子, 遠藤京子, 鬼頭宏彰. 炎症性腸疾患モデルマウスにおけるカルシウム活性化カリウムチャネルKCa3.1によるIL-10発現調節. 日本薬理学雑誌. 2021. 156. Supplement
-
鬼頭宏彰, 遠藤京子, 梶栗潤子, 大矢進. microRNAを介した内向き整流性カリウムチャネルKir2.1発現亢進による骨芽細胞分化制御機構. 日本薬理学雑誌. 2021. 156. Supplement
-
大矢進, 梶栗潤子, 鬼頭宏彰. ヒト骨肉腫スフェロイドモデルにおけるカルシウム活性化カリウムチャネル阻害による抗がん剤耐性克服. 日本癌学会学術総会抄録集(Web). 2021. 80th
more...
Return to Previous Page